InvestSMART

Elixinol Wellness Limited (ASX: EXL) - Announcements

- Current share price for EXL : $0.007

ASX company news and announcements for Elixinol Wellness Limited (EXL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Elixinol Wellness Limited (EXL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Elixinol Wellness Limited (EXL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Elixinol Wellness Limited (EXL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Exclusive distribution agreement for Belgium & Luxembourg 30 Aug 2019 8:50AM $2.290 $0.007 fallen by 99.69%
$3 H1 FY2019 Results Presentation 29 Aug 2019 8:48AM $2.420 $0.007 fallen by 99.71%
$3 H1 FY2019 Results Announcement 29 Aug 2019 8:47AM $2.420 $0.007 fallen by 99.71%
$3 Appendix 4D and Interim Report 29 Aug 2019 8:36AM $2.420 $0.007 fallen by 99.71%
$3 Exclusive CBD supply agreement with Pet Releaf 8 Aug 2019 8:59AM $2.900 $0.007 fallen by 99.76%
$3 Quarterly Report and Appendix 4C 30 Jul 2019 9:07AM $3.450 $0.007 fallen by 99.80%
$3 Elixinol partners with PharmaCare 29 Jul 2019 9:40AM $3.290 $0.007 fallen by 99.79%
$3 Elixinol continues to build Leadership team 23 Jul 2019 8:30AM $3.930 $0.007 fallen by 99.82%
$3 Global IP rights for microencapsulation technology acquired 22 Jul 2019 8:26AM $3.840 $0.007 fallen by 99.82%
$3 Final Directors Interest Notice - Linda McLeod 18 Jul 2019 1:58PM $3.890 $0.007 fallen by 99.82%
$3 Initial Directors Interest Notice - Stratos Karousos 18 Jul 2019 12:30PM $3.940 $0.007 fallen by 99.82%
$3 Nunyara Manufacturing Licence 17 Jul 2019 1:37PM $3.920 $0.007 fallen by 99.82%
$3 Leadership and Group Structure update 16 Jul 2019 8:23AM $4.100 $0.007 fallen by 99.83%
$3 MedVec Distribution Agreement Signed 4 Jul 2019 9:31AM $3.670 $0.007 fallen by 99.81%
$3 D&G Health Change of Substantial Holder 12 Jun 2019 9:56AM $3.900 $0.007 fallen by 99.82%
$3 Raw with Life Change of Substantial Holder 12 Jun 2019 9:55AM $3.900 $0.007 fallen by 99.82%
$3 EXL Change of Substantial Holder 12 Jun 2019 9:55AM $3.900 $0.007 fallen by 99.82%
$3 Cleansing Statement and Appendix 3B 12 Jun 2019 9:50AM $3.900 $0.007 fallen by 99.82%
$3 Strategic Partnership with RFI 11 Jun 2019 8:33AM $3.950 $0.007 fallen by 99.82%
$3 Elixinol Global raises A$50m to accelerate US expansion 5 Jun 2019 8:56AM $4.270 $0.007 fallen by 99.84%
$3 Trading Halt 4 Jun 2019 9:36AM $4.270 $0.007 fallen by 99.84%
$3 Appendix 3B 24 May 2019 3:25PM $5.210 $0.007 fallen by 99.87%
$3 Final Directors Interest Notice 24 May 2019 3:20PM $5.210 $0.007 fallen by 99.87%
$3 AGM Results 23 May 2019 1:37PM $5.380 $0.007 fallen by 99.87%
$3 2019 AGM CEO Presentation 23 May 2019 9:35AM $5.510 $0.007 fallen by 99.87%

526 - 550 of 680 results

Page 22 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.